Skip to main content

News

Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.

News

Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.

Could Your Biological Age Contribute to Early-Onset Cancer Risk?

October 26, 2026 - NCATS News

  • Clinical and Translational Science Awards (CTSA) Program

A recent study found that younger generations may be aging faster biologically than older generations, increasing the risk of early-onset cancer.

Choosing an Antidepressant: Art, Science, and Knowing Your Patient

October 16, 2026 - Grantee/Partner News

  • Clinical and Translational Science Awards (CTSA) Program

Yale Co-Leads New National Consortium for Rare Skin Disorders

October 12, 2026 - Grantee/Partner News

  • Our Impact on Rare Diseases
  • Rare Diseases Clinical Research Network (RDCRN)

A Technology Development Center Uses Human-Based Models to Discover Potential Treatments for Fibrotic Diseases

October 9, 2026 - NCATS News

  • 3-D Tissue Bioprinting

A multi-institute collaboration, including NCATS, is using human-based 3-D models, drug screening and AI to study fibrotic diseases and accelerate the identification of potential safe and efficacious treatments.

Study Identifies Protein Signature That Could Help Detect Advanced Fibrosis in Liver Disease

October 9, 2026 - Grantee/Partner News

  • Clinical and Translational Science Awards (CTSA) Program

The Complement-ARIE Program Aims to Create New Models That Mimic Human Biology

October 9, 2026 - NCATS News

  • 3-D Tissue Bioprinting

NCATS helps shape NIH’s Complement-ARIE program, which advances human-based NAMs to improve drug development, regulatory approval and patient outcomes.

Last updated on September 29, 2026